RecruitingPhase 4NCT06535945

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

Sponsor

Rennes University Hospital

Enrollment

400 participants

Start Date

Mar 26, 2025

Study Type

INTERVENTIONAL

Conditions

Acute Kidney Injury Liver Transplantation

Summary

To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Albumin administration for people with acute kidney injury and liver transplantation. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAlbumin administration

when albumin serum concentration is at 30 g/L or below

Locations(8)

08_CHRU de Tours Hôpital Trousseau

Chambray-lès-Tours, France

03_APHP Hôpital Beaujon

Clichy, France

04_CHU de Lille Hôpital Huriez

Lille, France

05_HCL Hôpital de la Croix Rousse

Lyon, France

06_CHU de Montpellier Hôpital St Eloi

Montpellier, France

02_CHU de Bordeaux - Hôpital Haut Leveque

Pessac, France

01_CHU de Rennes Hôpital Pontchaillou

Rennes, France

09_APHP Hôpital Paul Brousse

Villejuif, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06535945

Related Trials

Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

NCT035474141 location

Rectus-Intercostal Fascial Plane Block for Liver Transplantation Donors

NCT072330961 location

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

NCT058794329 locations

UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

NCT058066452 locations

Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury

NCT072364632 locations